Tool overview
Ibex Medical is listed under Computer Vision AI tools.
What is Ibex Medical?
Ibex Medical Analytics provides an AI-powered digital-pathology platform for cancer diagnosis. Its solutions support first-read and second-read workflows, tumor detection and grading, biomarker quantification, case prioritization, quality control, structured reporting, and integration with pathology systems.
Best for
Pathology laboratories and health systems adopting AI-assisted cancer diagnostics
Who is it for?
Decision note
Confirm intended tissue and use, country approvals, scanner and IMS/LIS compatibility, API and reporting integration, validation study, pathologist workflow, security, implementation, support, monitoring, and commercial terms.
Key features
AI-assisted cancer detection and grading
First-read and second-read pathology workflows
Breast biomarker quantification
Quality-control and case-prioritization tools
Open API and pathology-system integrations
Structured reporting with mTuitive
Use cases
Supporting prostate pathology review
Assisting breast and gastric cancer diagnosis
Prioritizing suspicious cases
Improving pathology quality control
Pros
- Deployed in routine clinical pathology workflows
- Supports multiple tissue-specific solutions
- Open API and broad partner ecosystem
Limitations
Ibex solutions are medical devices with indications and regulatory status that vary by product and country. They do not replace pathologists. Laboratories must verify intended use, approvals, scanner and workflow compatibility, image quality, findings, reports, cybersecurity, and every diagnosis.
Pricing details
Billing options
Custom healthcare agreement
Pricing note
Ibex Medical Analytics uses an institutional sales and implementation process and does not publish a stable starting amount. No ongoing free plan or formal free trial was confirmed.
Supported languages
- English
Integrations
Digital slide scanners
Image management systems
Laboratory information systems
Philips IntelliSite
mTuitive structured reporting
Please log in to join the discussion.